Research output
- 2 Article
-
Regulatory T cells in the mouse hypothalamus control immune activation and ameliorate metabolic impairments in high-calorie environments
Becker, M., Kälin, S., Neubig, A. H., Lauber, M., Opaleva, D., Hipp, H., Salb, V. K., Ott, V. B., Legutko, B., Kälin, R. E., Hippich, M., Scherm, M. G., Nascimento, L. F. R., Serr, I., Hosp, F., Nikolaev, A., Mohebiany, A., Krueger, M., Flachmeyer, B. & Pfaffl, M. W. & 10 others, , 20 Mar 2025, In: Nature Communications. 16, 1, 23 p., 2744.Research output: Contribution to journal › Article › peer-review
Open Access -
Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signaling
Cheng, J., Li, M., Motta, E., Barci, D., Song, W., Zhou, D., Li, G., Zhu, S., Yang, A., Vaillant, B. D., Imhof, A., Forné, I., Spiegl-Kreinecker, S., Zhang, N., Katayama, H., Bhat, K. P. L., Flüh, C., Kälin, R. & Glass, R., 20 Aug 2024, In: Cell Reports Medicine. 5, 8, 28 p., 101658.Research output: Contribution to journal › Article › peer-review
Open Access
Projects
- 1 Active
-
Tumorsezernierte Signale als chemo-attraktive Faktoren für Gliom-invadierende Zellen und deren Rolle als immuntherapeutisches Angriffsziel
Spiegl-Kreinecker, S. (Researcher), Kälin, R. (Researcher) & Pitigala-Motal, L. (Researcher)
01.09.2024 → 31.08.2028
Project: Clinical studies › Clinical Study (Academic - no third-party funds)
-
Glioblastoma Cell-Derived APLN Shows Differential Effects on Myeloid Cell Migration
Kälin, R. (Speaker)
13 Nov 2025Activity: Talk or presentation › Contributed talk › science-to-science
-
GLIOBLASTOMA CELL-DERIVED APLN SHOWS DIFFERENTIAL EFFECTS ON MYELOID CELL MIGRATION
Kälin, R. (Speaker)
18 Oct 2025Activity: Talk or presentation › Contributed talk › science-to-science
-
Glioblastoma cell-derived APLN shows differential effects on myeloid cell migration
Kälin, R. (Speaker)
07 Oct 2025Activity: Talk or presentation › Contributed talk › science-to-science
-
New treatment strategies for simultaneous targeting of systemic and cell autonomous resistance to glioblastoma therapy
Kälin, R. (Speaker)
17 Jan 2025Activity: Talk or presentation › Invited talk › science-to-science